Clarity Pharmaceuticals

(ASX) CU6

Current PriceA$2.15

Market CapA$801.89M

Since IPO (2021)+44%

5 YearN/A

1 Year-8%

1 Month-25%

Clarity Pharmaceuticals Financials at a Glance

Market Cap

A$801.89M

Revenue (TTM)

A$15.55M

Net Income (TTM)

-A$144.95M

EPS (TTM)

-A$0.28

P/E Ratio

-7.70

Dividend

A$0.00

Beta (Volatility)

0.02 (Low)

Dividend

A$0.00

Beta (Volatility)

0.02 (Low)

Price

A$2.15

Volume

2,081,315

Open

A$2.11

Price

A$2.15

Volume

2,081,315

Open

A$2.11

Previous Close

A$2.15

Daily Range

A$2.09 - A$2.20

52-Week Range

A$1.97 - A$5.87

Estimated Earnings Date

Aug 26, 2026

Dividend

A$0.00

Beta (Volatility)

0.02 (Low)

Price

A$2.15

Volume

2,081,315

Open

A$2.11

Previous Close

A$2.15

Daily Range

A$2.09 - A$2.20

52-Week Range

A$1.97 - A$5.87

Estimated Earnings Date

Aug 26, 2026

CU6 News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Clarity Pharmaceuticals

Industry

Pharmaceuticals

Sector

Health Care

CEO

Michelle Parker

Website

www.claritypharmaceuticals.com

Headquarters

Sydney, NSW 2015, AU

CU6 Financials

Key Financial Metrics (TTM)

Gross Margin

97%

Operating Margin

-21%

Net Income Margin

-20%

Return on Equity

-53%

Return on Capital

-44%

Return on Assets

-38%

Earnings Yield

-12.99%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$801.89M

Shares Outstanding

372.97M

Volume

2.08M

Avg. Volume

2.38M

Financials (TTM)

Gross Profit

A$9.46M

Operating Income

-A$69.09M

EBITDA

-A$68.91M

Operating Cash Flow

-A$54.77M

Capital Expenditure

-A$182.74K

Free Cash Flow

-A$54.95M

Cash & ST Invst.

A$84.12M

Total Debt

A$0.00

Clarity Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

A$0.00

-100.0%

Gross Profit

-A$150.62K

-105.7%

Gross Margin

0.00%

N/A

Market Cap

A$801.89M

N/A

Market Cap/Employee

A$16.04M

N/A

Employees

N/A

Net Income

-A$55.53M

-222.8%

EBITDA

-A$62.31M

-177.4%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

A$226.25M

+495.7%

Total Debt

A$0.00

N/A

Accounts Receivable

A$16.81M

+9.2%

Inventory

A$0.00

N/A

Long Term Debt

A$0.00

N/A

Short Term Debt

A$0.00

N/A

Return on Assets

-37.65%

N/A

Return on Invested Capital

-43.61%

N/A

Free Cash Flow

-A$48.05M

-77.0%

Operating Cash Flow

-A$47.79M

-79.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

PYC.AXPYC Therapeutics Limited

PYC.AXPYC Therapeutics LimitedA$1.22+3.39%

NAN.AXNanosonics Limited

NAN.AXNanosonics LimitedA$3.32+0.00%

CUV.AXClinuvel Pharmaceuticals Limited

CUV.AXClinuvel Pharmaceuticals LimitedA$8.96+1.24%

OCC.AXOrthocell Limited

OCC.AXOrthocell LimitedA$0.74-1.34%

DXB.AXDimerix Limited

DXB.AXDimerix LimitedA$0.17-2.94%

ILA.AXIsland Pharmaceuticals Limited

ILA.AXIsland Pharmaceuticals LimitedA$0.38+7.04%

IMM.AXImmutep Limited

IMM.AXImmutep LimitedA$0.05+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$160.95+0.19%

AALAmerican Airlines Group

AALAmerican Airlines Group$14.98+0.02%

NOKNokia

NOKNokia$14.80+0.05%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.52+0.02%

SMCISuper Micro Computer

SMCISuper Micro Computer$30.46-0.05%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.04-0.02%

Questions About CU6

What is the current price of Clarity Pharmaceuticals?

Clarity Pharmaceuticals is trading at A$2.15 per share.

What is the 52-week range for Clarity Pharmaceuticals?

Over the past 52 weeks, Clarity Pharmaceuticals has traded between A$1.97 and A$5.87.

How much debt does Clarity Pharmaceuticals have?

As of the most recent reporting period, Clarity Pharmaceuticals reported total debt of A$0.00.

How much cash does Clarity Pharmaceuticals have on hand?

Clarity Pharmaceuticals reported A$84.12M in cash and cash equivalents in its most recent financial results.

What is Clarity Pharmaceuticals’s dividend yield?

Clarity Pharmaceuticals does not currently have a dividend yield.

Clarity Pharmaceuticals

Clarity Pharmaceuticals Financials at a Glance

CU6 News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Clarity Pharmaceuticals

CU6 Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Clarity Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CU6

What is the current price of Clarity Pharmaceuticals?

What is the 52-week range for Clarity Pharmaceuticals?

How much debt does Clarity Pharmaceuticals have?

How much cash does Clarity Pharmaceuticals have on hand?

What is Clarity Pharmaceuticals’s dividend yield?

Premium Investing Services